<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A serum ELISA using a monoclonal antibody that detects a MUC5AC-related antigen (NPC-1C antigen) expressed by pancreatic and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was developed </plain></SENT>
<SENT sid="1" pm="."><plain>The NPC-1C antibody reacts with specific <z:chebi fb="0" ids="53000">epitopes</z:chebi> expressed by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated MUC5AC that does not appear on MUC5AC from <z:mpath ids='MPATH_458'>normal</z:mpath> tissues </plain></SENT>
<SENT sid="2" pm="."><plain>Based on observations of a highly specific antibody, we tested the ELISA to differentiate serum from healthy blood donors compared to serum from patients with colorectal or <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Additionally, patient <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue was stained to examine the expression pattern of MUC5AC-related antigen in pancreatic and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The results indicate the NPC-1C antibody ELISA distinguished serum of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients from <z:mpath ids='MPATH_458'>normal</z:mpath> donors with very good sensitivity and specificity </plain></SENT>
<SENT sid="5" pm="."><plain>Most patient's <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> biopsy exhibited NPC-1C antibody reactivity, indicating that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated MUC5AC antigen from <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> is shed into blood, where it can be detected by the NPC-1C antibody ELISA </plain></SENT>
<SENT sid="6" pm="."><plain>This serum test provides a new tool to aid in the diagnosis of these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and immune monitoring of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> treatment regimens </plain></SENT>
</text></document>